000 | 01292 a2200325 4500 | ||
---|---|---|---|
005 | 20250517084152.0 | ||
264 | 0 | _c20170126 | |
008 | 201701s 0 0 eng d | ||
022 | _a1469-0691 | ||
024 | 7 |
_a10.1016/j.cmi.2016.02.012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGiacobbe, D R | |
245 | 0 | 0 |
_aIs initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response. _h[electronic resource] |
260 |
_bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _cJun 2016 |
||
300 |
_a579 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 |
_aCandidemia _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProteoglycans |
650 | 0 | 4 |
_aSerum _xchemistry |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 |
_abeta-Glucans _xblood |
700 | 1 | _aViscoli, C | |
700 | 1 | _aFurfaro, E | |
700 | 1 | _aColombo, A L | |
700 | 1 | _aDel Bono, V | |
773 | 0 |
_tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _gvol. 22 _gno. 6 _gp. 579 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cmi.2016.02.012 _zAvailable from publisher's website |
999 |
_c25820954 _d25820954 |